Introduction Executive Summary Plasminogen activators: Overview • Structure • Mechanism of Action Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Plasminogen activators – DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Plasminogen activators companies’ collaborations, Licensing, Acquisition -Deal Value Trends Plasminogen activators Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis Recombinant staphylokinase: Supergene • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis TMS 007: TMS • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis CS-1: Cereno Scientific • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Pre-clinical and Discovery Stage Products • Comparative Analysis Drug name: Company name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Plasminogen activators Key Companies Plasminogen activators Key Products Plasminogen activators- Unmet Needs Plasminogen activators- Market Drivers and Barriers Plasminogen activators- Future Perspectives and Conclusion Plasminogen activators Analyst Views Plasminogen activators Key Companies Appendix

Table 1 Total Products for Plasminogen activators Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Genentech • TMS • Tasly Pharmaceutical • Cereno Scientific • Supergene • Boehringer Ingelheim • Chiesi Farmaceutici